BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.90
-0.06 (-0.55%)
May 22, 2026, 5:00 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 45.7 million as of May 22, 2026. Its market cap has decreased by -13.15% in one year.
Market Cap
45.70M
Enterprise Value
60.56M
Revenue
59.11M
Ranking
n/a
PE Ratio
72.67
Stock Price
10.90
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 45.70M, an increase of 300.79%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 45.70M | -9.54% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.44B |
| NEUCA | 3.42B |
| Synektik Spólka Akcyjna | 2.41B |
| Celon Pharma | 1.13B |
| Read-Gene | 59.66M |
| Urteste | 59.49M |
| Sygnis | 38.81M |
| Pharmena | 37.65M |